Join to View Full Profile
1365 Clifton Rd NeAtlanta, GA 30322
Phone+1 404-778-1900
Dr. Saba is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of TorontoFellowship, Stem cell transplantation , 1998 - 1999
Rhode Island Hospital/Brown University HealthFellowship, Hematology and Medical Oncology, 1994 - 1997
Mass General Brigham/Brigham and Women's HospitalResidency, Internal Medicine, 1992 - 1994
University of Wisconsin Hospitals and ClinicsResidency, Internal Medicine, 1990 - 1992
American University of Beirut Faculty of MedicineClass of 1990
Certifications & Licensure
GA State Medical License 2003 - 2027
MA State Medical License 1993 - 2004
MN State Medical License 1999 - 2004
RI State Medical License 1995 - 1996
American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Inaugural Lynne and Howard Halpern Chair in HNCA Research Winship Cancer Institute, Emory University, 2021-2025
- Atlanta Magazine: Top Doctors Castle Connolly, 2005, 2016
- Distinguished Doctor Expert Network, 2015
Clinical Trials
- Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma Start of enrollment: 2008 Aug 08
- Study of Cetuximab and Bevacizumab in Cancer of the Esophagus After Failure of Patient's First Therapy Start of enrollment: 2008 Oct 01
- Dasatinib in Treating Patients With Recurrent or Metastatic Malignant Salivary Gland Tumors Start of enrollment: 2009 Mar 16
Publications & Presentations
PubMed
- Minimizing Chemoradiation Using a Surgical Algorithm for HPV-Associated Cancer of Unknown Primary.Georges E Daoud, Andre J Burnham, Nikhil T Vettikattu, Nicole C Schmitt, Brian J Boyce
Head & Neck. 2026-05-01 - Colocated Multidisciplinary Clinic Is Associated With Improved Timeliness to Postoperative Adjuvant Therapy in Head and Neck Cancer Patients.Georges E Daoud, Melissa F Riedel, Martha J Ryan, Mokshad Gaonkar, Mitesh P Mehta
Head & Neck. 2026-04-06 - In Response to A Clinical Consensus Statement on Pulmonary Recurrent Respiratory Papillomatosis.Nikita Kohli, Sara I Pai, Julia Buckingham, Yvonne Carter, Nabil F Saba
The Laryngoscope. 2026-04-01
Journal Articles
- Concurrent Chemoradiotherapy with Weekly Versus Triweekly Cisplatin in Locally Advanced Squamous Cell Carcinoma of the Head and Neck: A Comparative AnalysisRathi Pillai, Fadlo R Khuri, Nabil F Saba, Conor Steuer, Suchita Pakkala, Kristin Higgins, Jonathan J Beitler, Suresh S Ramalingam, Brandon Twardy, Kelly Schrapp, Taof..., Head & Neck
- Disparities in Postoperative Therapy for Salivary Gland Adenoid Cystic CarcinomasJonathan J Beitler, Ryan H Belcher, Richard J Cassidy, Jim Zhong, Conor E Steuer, Nabil F Saba, The Laryngoscope
- Interleukin-6/STAT3 Signaling Is Prominent and Associated with Reduced Overall Survival in p16 Negative Oropharyngeal Squamous Cell CarcinomaNabil F Saba, Dong M Shin, Head and Neck Pathology
Lectures
- Nivolumab (nivo) vs investigatoras choice (IC) in patients (pts) with recurrent or metastatic (R/M) squamous cell carcinoma of the head and neck (SCCHN): Analysis of C...2018 ASCO Annual Meeting - Chicago, Illinois - 06/2/2018
Other
- Posttreatment surveillance of squamous carcinoma of the head and neckSaba NF
http://www.uptodate.com/contents/posttreatment-surveillance-of-squamous-carcinoma-of-the-head-and-ne
UpToDate, Wolters Kluwer Health - 2013-01-22
Press Mentions
Neoadjuvant Chemo Boosts Structure Preservation Rates in Nasal, Sinus CancerSeptember 19th, 2024- Head and Neck Cancer Awareness Month: 2022 Immunotherapy Research UpdatesApril 3rd, 2022
- Dr. Nabil F. Saba Answers Questions About Head and Neck Cancer and Immunotherapy After the 2021 CRI Virtual Immunotherapy Patient SummitDecember 10th, 2021
Grant Support
- Atorvastatin to Reduce Cisplatin-Induced Hearing Loss in Head and Neck Cancer PatientsEMORY UNIVERSITY2023–2028
- Winship National Clinical Trials Network Lead Academic Participating SiteEMORY UNIVERSITY2025–2026
Committees
- Chair, Chair- NCI steering committee task force on RM HNCA 2017 - Present
- Member, Dean's advisory committee - Emory University School of Medicine 2017 - Present
- Chair, Chair-NCI head and neck cancer steering committee on rare diseases 2016 - Present
- Member, NRG- Head and Neck Cancer Core Committee 2016 - Present
- Principal Author, Member, Committee on Appropriateness Criteria, Expert Panel on Radiation Oncology - Head & Neck Cancer, American College of Radiology 2015 - Present
Professional Memberships
- Member
- Fellow
- AHNSMember
Other Languages
- French, Arabic
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
